1. Arthritic psoriasis during natalizumab treatment: a case report and review of the literature
- Author
-
Matteo Foschi, Alessandra Lugaresi, Veria Vacchiano, Loredana Sabattini, Cinzia Scandellari, and DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Neurology (clinical) ,Psychiatry and Mental Health ,natalizumab, psoriasis, multiple sclerosis, treatment ,Neurology ,treatment ,business.industry ,Arthritic psoriasis ,psoriasis ,Dermatology ,General Medicine ,multiple sclerosis ,03 medical and health sciences ,Psychiatry and Mental health ,natalizumab ,030104 developmental biology ,0302 clinical medicine ,Natalizumab ,medicine ,Neurosurgery ,business ,030217 neurology & neurosurgery ,Neuroradiology ,medicine.drug - Abstract
none 6 no Psoriasis and multiple sclerosis (MS) are both considered T cell-mediated diseases, with similarities in the pathophysiology.To our knowledge, only a case of severe disseminated psoriasis eruption has been described during natalizumab treatment [3]. We describe a patient affected by relapsing remitting (RR)MS with new-onset psoriatic arthritis during natalizumab treatment. In conclusion, taking into account the possible genetic susceptibility for cutaneous autoimmune diseases, we believe that it is important to investigate not only personal, but also family history for autoimmune comorbidities, to select the most suitable disease-modifying treatment for each MS patient. mixed Vacchiano, V.; Foschi, M.; Sabattini, L.; Scandellari, C.; Lugaresi, A. Vacchiano, V.; Foschi, M.; Sabattini, L.; Scandellari, C.; Lugaresi, A.
- Published
- 2017
- Full Text
- View/download PDF